Aeolus Pharmaceuticals, Inc. (AOLS)

USD 0.0

(0.0%)

Annual Cash Flows

(In USD)
Breakdown 2023 2022 2021 2020 2019 2016
Operating Cash Flow - - - - - -3.1 Million
Net Income - - - - - -3.55 Million
Depreciation & Amortization - - - - - -
Deferred income taxes - - - - - -
Stock-based compensation - - - - - 141 Thousand
Change in working capital - - - - - 23 Thousand
Other non-cash items - - - - - 426 Thousand
Investing Cash Flow - - - - - -
Investments in PPE - - - - - -
Acquisitions - - - - - -
Investment purchases - - - - - -
Sales/Maturities of investments - - - - - -
Other Investing Activities - - - - - -
Financing Cash Flow - - - - - 6.17 Million
Debt repayment - - - - - -
Dividends payments - - - - - -
Common Stock Repurchased - - - - - -
Common Stock Issuance - - - - - 6.17 Million
Other Financing Activities - - - - - 6.17 Million
Accounts receivables - - - - - 835 Thousand
Accounts payables - - - - - -626 Thousand
Inventory - - - - - -
Other working capital - - - - - -812 Thousand
Cash at beginning of period - - - - - 94 Thousand
Cash at end of period - - - - - 3.15 Million
Capital Expenditure - - - - - -
Effect of forex changes on cash - - - - - -
Net cash flow / Change in cash - - - - - 3.06 Million
Free Cash Flow - - - - - -3.1 Million

Cash Flow Charts